Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-22

Clinical Trial Update: EFFICACY and TOLERABILITY of TESTED FORMULA VS. HYDROQUINONE 4% in the TREATMENT of FACIAL MELASMA [NA]

View source ↗

Summary

A completed clinical trial comparing a tested topical formula with hydroquinone 4% for facial melasma evaluated for efficacy and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroquinone 4% (hydroquinone)
  • Tested Formula

Snippet

Sponsor: Cosmetique Active International | Conditions: Melasma | NA | Status: COMPLETED